Safe and well-tolerated treatment for episodic cluster headache patients
Clinical trials have demonstrated the safety of gammaCore (nVNS).1,2
- No serious gammaCore side effects were reported in clinical trials1,2
- Most gammaCore side effects are mild, occur during use of the device, and go away quickly after each treatment1,2
Patients may sometimes experience hoarseness, shortness of breath, or change in voice during treatment. A tingling/pricking feeling where the device is applied is normal, but it should not cause major discomfort. These effects usually stop once the treatment is completed.2
- gammaCore has been used in Canada and Europe for several years3
- gammaCore has been cleared by the FDA (Food and Drug Administration) for use in the United States
References: 1. Silberstein SD, Mechtler LL, Kudrow DB, et al; ACT1 Study Group. Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache. 2016;56(8):1317-1332. 2. gammaCore Instructions for Use. Basking Ridge, NJ: electroCore, LLC; 2017. 3. Data on file, electroCore, LLC.